The advent of glucagon-like peptide-1 (GLP-1) receptor agonists, exemplified by medications like Ozempic (semaglutide), marks a significant milestone in the ...
Immigration policies in the United States have historically been intertwined with public health concerns, particularly regarding the transmission of communicable ...
The sudden freeze of National Institutes of Health (NIH) operations.
Trump’s COVID revenge begins with he Trump administration's freeze on NIH operations and federal health agency communications sending the scientific ...
For most physicians, the difference between statutory law and case law might seem as irrelevant as the difference between Shakespearean ...
An amicus brief allows a third party to provide information, expertise, or insight that has a bearing on a court ...
Medicine and drug discovery aren’t the only things that require clinical trials. We’re exploring the top reasons new medical devices ...
Learn key strategies for caregivers to improve post-surgery sleep. Pain management, supportive bedding, and a calm environment support faster recovery.
Accessibility in health care, especially in eye clinics, plays a crucial role in ensuring all patients receive equitable care. Making ...
Healthcare providers are constantly looking for ways to enhance patient care. In this blog, you’ll discover ideas for improving at-home ...
Here is a deeper look into the often overlooked yet crucial practices and standards that ensure the highest quality in ...
Patient care is invaluable, and more work is going into improving it every year. Here are some ways healthcare practices ...
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy